Do no harm--normal tissue effects.
Radiation therapy confers enormous benefits that must be balanced against the possibilities for harm including late toxicity in normal tissues and radiation-induced second malignancies. A small percentage of patients experience severe late complications. The question is, do these late sequelae occur randomly, or are they confined to individuals who are genetically predisposed to radiosensitivity. Experiments with knockout mice and with patients demonstrate that individuals heterozygous for a number of genes appear to be radiosensitive. If radiosensitive patients were identified prospectively by genetic analysis, they could be spared the trauma of late sequelae. Several large studies have shown a statistically significant excess of radiation-induced malignancies in radiotherapy patients. Most second cancers are carcinomas, developing in the lining cells of the body often remote from the treatment site. Radiation-induced sarcomas appear only in the heavily irradiated areas. These are small in number but appear with a very high relative risk.
Hall
E J
EJ
Center for Radiological Research, Columbia University, College of Physicians & Surgeons, New York 10032, USA. ejhl@columbia.edu
D000818:Animals; D002277:Carcinoma / Q000209:etiology; D020022:Genetic Predisposition to Disease; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D011832:Radiation Injuries / Q000235:genetics / Q000503:physiopathology* / Q000517:prevention & control*; D018787:Radiation Oncology / Q000639:trends; D011878:Radiotherapy / Q000009:adverse effects*; D012307:Risk Factors; D012509:Sarcoma / Q000209:etiology; D012983:Soft Tissue Neoplasms / Q000209:etiology